Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110318
Status:
COMPLETED
Last Update Posted:
2013-12-11
First Post:
2005-05-05
Brief Title:
Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia
Sponsor:
The University of Queensland
Organization:
The University of Queensland
Study Overview
Official Title:
A Pragmatic Randomised Controlled Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This randomised controlled trial will evaluate the role of manual therapy and therapeutic exercise and corticosteroid injections in the treatment of lateral epicondylalgia tennis elbow
Detailed Description:
Musculoskeletal conditions account for the third leading cause of health systems expenditure in Australia Lateral epicondylalgia tennis elbow is a painful musculoskeletal condition that is often treated in primary care Seven out of every 1000 patients seeing their general medical practitioner do so for this condition though most are not tennis related On average 10-30 of sufferers take 12 weeks of absenteeism from work and the condition may last 6-48 months
Two popular treatment options that are commonly prescribed for the management of lateral epicondylalgia are manual therapytherapeutic exercise and corticosteroid injections To date there is little evidence that supports manual therapytherapeutic exercise This lack of evidence is largely due to the small number of studies of physiotherapy treatments most of which are of poor quality The small number of studies of manual therapy contrasts with the larger number of studies of corticosteroid injections which show that corticosteroid injections are beneficial in the short term 3-6 weeks but they are associated with significantly greater recurrence rates and offer no advantage in the long term 12 months The efficacy of a manual therapy and therapeutic exercise programme compared to that of corticosteroid injections is unknown at this stage
This randomised controlled trial will evaluate the role of manual therapy and therapeutic exercise in the treatment of lateral epicondylalgia The factors associated with success or failure of these common treatment options for lateral epicondylalgia will also be examined A tangible outcome of this project will be the development of clinical guidelines for the most effective method of treating lateral epicondylalgia
Two popular treatment options that are commonly prescribed for the management of lateral epicondylalgia are manual therapytherapeutic exercise and corticosteroid injections To date there is little evidence that supports manual therapytherapeutic exercise This lack of evidence is largely due to the small number of studies of physiotherapy treatments most of which are of poor quality The small number of studies of manual therapy contrasts with the larger number of studies of corticosteroid injections which show that corticosteroid injections are beneficial in the short term 3-6 weeks but they are associated with significantly greater recurrence rates and offer no advantage in the long term 12 months The efficacy of a manual therapy and therapeutic exercise programme compared to that of corticosteroid injections is unknown at this stage
This randomised controlled trial will evaluate the role of manual therapy and therapeutic exercise in the treatment of lateral epicondylalgia The factors associated with success or failure of these common treatment options for lateral epicondylalgia will also be examined A tangible outcome of this project will be the development of clinical guidelines for the most effective method of treating lateral epicondylalgia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NHMRC252710 | None | None | None |